{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:36:16Z","timestamp":1793298976913,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00c3\u00bcr Gesundheit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.preghy.2018.04.022","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T23:07:23Z","timestamp":1526684843000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Increased rate of birth defects after first trimester use of angiotensin converting enzyme inhibitors \u2013 Treatment or hypertension related? An observational cohort study"],"prefix":"10.1016","volume":"13","author":[{"given":"Maria","family":"Hoeltzenbein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Tissen-Diabat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4395-4176","authenticated-orcid":false,"given":"Anne-Katrin","family":"Fietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Zinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Kayser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Meister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Weber-Schoendorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.preghy.2018.04.022_b0005","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa055202","article-title":"Major congenital malformations after first-trimester exposure to ACE inhibitors","volume":"354","author":"Cooper","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.preghy.2018.04.022_b0010","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/bdra.23027","article-title":"Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence, Birth defects research","volume":"94","author":"Polifka","year":"2012","journal-title":"Part A Clin. Mol. Teratol."},{"issue":"2","key":"10.1016\/j.preghy.2018.04.022_b0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/17512433.2015.1005074","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits","volume":"8","author":"Pucci","year":"2015","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.preghy.2018.04.022_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.10.878","article-title":"Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions","volume":"206","author":"Bateman","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.preghy.2018.04.022_b0025","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMsa1506575","article-title":"Declines in unintended pregnancy in the United States, 2008\u20132011","volume":"374","author":"Finer","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.preghy.2018.04.022_b0030","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/HJH.0000000000001456","article-title":"In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review","volume":"35","author":"Fitton","year":"2017","journal-title":"J. Hypertens."},{"issue":"1","key":"10.1016\/j.preghy.2018.04.022_b0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/AOG.0000000000001775","article-title":"Angiotensin-converting enzyme inhibitors and the risk of congenital malformations","volume":"129","author":"Bateman","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2018.04.022_b0040","doi-asserted-by":"crossref","first-page":"d5931","DOI":"10.1136\/bmj.d5931","article-title":"Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study","volume":"343","author":"Li","year":"2011","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.preghy.2018.04.022_b0045","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/HYPERTENSIONAHA.116.08773","article-title":"Maternal antihypertensive medication use and congenital heart defects: updated results from the national birth defects prevention study","volume":"69","author":"Fisher","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2018.04.022_b0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ajmg.c.30303","article-title":"The role of teratology information services in screening for teratogenic exposures: challenges and opportunities","volume":"157","author":"Chambers","year":"2011","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.preghy.2018.04.022_b0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.reprotox.2016.02.002","article-title":"Field studies versus database studies on the risks and benefits of medication use during pregnancy: distinct pieces of the same puzzle","volume":"60","author":"Berard","year":"2016","journal-title":"Reprod. Toxicol."},{"issue":"2","key":"10.1016\/j.preghy.2018.04.022_b0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00228-017-2351-y","article-title":"Drug safety in pregnancy: the German Embryotox institute","volume":"74","author":"Dathe","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.preghy.2018.04.022_b0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.reprotox.2008.05.064","article-title":"Using observational cohort data for studying drug effects on pregnancy outcome \u2013 methodological considerations","volume":"26","author":"Schaefer","year":"2008","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.preghy.2018.04.022_b0070","unstructured":"EUROCAT, European surveillance of congenital anomalies: Malformation Coding Guides, 2017. <http:\/\/www.eurocat-network.eu\/aboutus\/datacollection\/guidelinesforregistration\/malformationcodingguides> (accessed 24.11.2017)."},{"issue":"1","key":"10.1016\/j.preghy.2018.04.022_b0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.reprotox.2008.06.006","article-title":"Statistical methods for estimating the probability of spontaneous abortion in observational studies\u2013analyzing pregnancies exposed to coumarin derivatives","volume":"26","author":"Meister","year":"2008","journal-title":"Reprod. Toxicol."},{"issue":"1","key":"10.1016\/j.preghy.2018.04.022_b0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1055\/s-0029-1241833","article-title":"Kurzmitteilung zu den Perzentilwerten f\u00fcr die K\u00f6rperma\u00dfe der Neugeborenen","volume":"214","author":"Voigt","year":"2010","journal-title":"Z. Geburtshilfe Neonatologie"},{"key":"10.1016\/j.preghy.2018.04.022_b0085","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat. Med."},{"issue":"4","key":"10.1016\/j.preghy.2018.04.022_b0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1037\/1082-989X.9.4.403","article-title":"Propensity score estimation with boosted regression for evaluating causal effects in observational studies","volume":"9","author":"McCaffrey","year":"2004","journal-title":"Psychol. Methods"},{"key":"10.1016\/j.preghy.2018.04.022_b0095","series-title":"Statistical Analysis with Missing Data","author":"Little","year":"2002"},{"key":"10.1016\/j.preghy.2018.04.022_b0100","series-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","year":"2004"},{"key":"10.1016\/j.preghy.2018.04.022_b0105","unstructured":"R Core Team, A language and environment for statistical computing. R Foundation for Statistical Computing, , 2016. <www.R-project.org> (accessed 7.6.2017)."},{"issue":"4","key":"10.1016\/j.preghy.2018.04.022_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v038.i04","article-title":"Empirical transition matrix of multi-state models: the etm package","volume":"38","author":"Allignol","year":"2011","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.preghy.2018.04.022_b0115","unstructured":"T. Therneau, A Package for Survival Analysis in S_. version 2.38, 2015. <https:\/\/CRAN.R-project.org\/package=survival> (accessed 7.6.2017)."},{"issue":"6","key":"10.1016\/j.preghy.2018.04.022_b0120","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00228-009-0620-0","article-title":"Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants","volume":"65","author":"Lennestal","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.preghy.2018.04.022_b0125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/1471-0528.12066","article-title":"Pregnancy outcome following maternal exposure to statins: a multicentre prospective study","volume":"120","author":"Winterfeld","year":"2013","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.preghy.2018.04.022_b0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejogrb.2012.03.015","article-title":"Association of pre-eclampsia with or without superimposed chronic hypertension in pregnant women with the risk of congenital abnormalities in their offspring: a population-based case-control study","volume":"163","author":"Banhidy","year":"2012","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"3","key":"10.1016\/j.preghy.2018.04.022_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.09.031","article-title":"Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study","volume":"212","author":"Bateman","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.preghy.2018.04.022_b0140","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1007\/s00246-015-1182-9","article-title":"Maternal hypertension during pregnancy and the risk of congenital heart defects in offspring: a systematic review and meta-analysis","volume":"36","author":"Ramakrishnan","year":"2015","journal-title":"Pediatr. Cardiol."},{"issue":"4","key":"10.1016\/j.preghy.2018.04.022_b0145","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.reprotox.2011.02.008","article-title":"Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers","volume":"31","author":"Diav-Citrin","year":"2011","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.preghy.2018.04.022_b0150","doi-asserted-by":"crossref","unstructured":"M.E. Moretti, D. Caprara, I. Drehuta, E. Yeung, S. Cheung, L. Federico, G. Koren, The fetal safety of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers, Obstet. Gynecol. Int. 2012, Article ID 658310.","DOI":"10.1155\/2012\/658310"},{"key":"10.1016\/j.preghy.2018.04.022_b0155","doi-asserted-by":"crossref","first-page":"g2301","DOI":"10.1136\/bmj.g2301","article-title":"Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis","volume":"348","author":"Bramham","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.preghy.2018.04.022_b0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.reprotox.2016.11.019","article-title":"Who seeks Teratology Information Service's advice? Assessing the risk of selection bias in observational cohort studies on drug risks in pregnancy","volume":"67","author":"Beck","year":"2017","journal-title":"Reprod. Toxicol."},{"issue":"6","key":"10.1016\/j.preghy.2018.04.022_b0165","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/aje\/kwm367","article-title":"Sensitivity and specificity of computerized algorithms to classify gestational periods in the absence of information on date of conception","volume":"167","author":"Toh","year":"2008","journal-title":"Am. J. Epidemiol."},{"issue":"8","key":"10.1016\/j.preghy.2018.04.022_b0170","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/pds.796","article-title":"Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment","volume":"12","author":"Tabacova","year":"2003","journal-title":"Pharmacoepidemiol. Drug Saf."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778917304233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778917304233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:53:20Z","timestamp":1761897200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778917304233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":34,"alternative-id":["S2210778917304233"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2018.04.022","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased rate of birth defects after first trimester use of angiotensin converting enzyme inhibitors \u2013 Treatment or hypertension related? An observational cohort study","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2018.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}